# Amrisha Bhosle et al

# Molecular Systems Biology

# log2(abundance)

# A

|Size|Pri-Std|Pri-Unan|Non-Pri-Std|Non-Pri-Unan|
|---|---|---|---|---|
|C16 carnitine|l|l|l|l|
|C10:2 carnitine|l|l|l|l|
|ketodeoxycholate|l|l|l|l|
|cholate|l|l|l|l|
|QI11694: phenylalanocholic acid|l|l|l|l|
|deoxycholate|l|l|l|l|
|taurine|l|l|l|l|
|taurocholate|l|l|l|l|
|alpha-muricholate|l|l|l|l|
|taurochenodeoxycholate|l|l|l|l|
|QI6230: isolithocholate|l|l|l|l|
|glycochenodeoxycholate|l|l|l|l|
|glycocholate|l|l|l|l|
|lithocholate|l|l|l|l|
|glycoursodeoxycholate|l|l|l|l|
|biotin|l|l|l|l|
|hippurate|l|l|l|l|

# B

|log 2(Count)|Modules|
|---|---|
|stercobilin|l|
|diacetylspermine|l|
|N-acetylputrescine|l|
|putrescine|l|
|N1,N12-diacetylspermine|l|
|eicosatrienoate|l|
|adrenate|l|
|docosapentaenoate|l|
|hydrocinnamate|l|
|4-methylcatechol|l|
|C38:5 DAG|l|
|C56:7 TAG|l|
|betaine|l|
|alpha-glycerophosphocholine|l|
|pantothenate|l|
|p-hydroxyphenylacetate|l|

# C

Reduction of bilirubin by gut microbes

# D

|HILp_QI22689|HILp_QI23086|∆m/z|
|---|---|---|
|0.9; 0.8|HILp_QI21471|60.0222|

# E

|Phenotype|nonIBD|UC|CD.nondys|CD.dys|
|---|---|---|---|---|
|GF|***|***|***|***|
|SPF|***|***|***|***|

# F

|Stercobilin|HILp_QI22686|HILp_QI22738|HILp_QI22234|HILp_QI21470|
|---|---|---|---|---|
|30|20|15|10|5|
|0|0|43.9907|46.0041|31.9900|

Relatedly, metabolite classes not previously linked directly to metabolism such as hydrocinnamate (Menni et al, 2020), inflammation in the gut were also highly prioritized. These 4-methylcatechol (Kolomytseva et al, 2007), stercobilin (Vitek et al, 2006), N-acetylputrescine (Murray et al, 1993), and methylnicotinamide, glycerides, betaine and choline derivatives, p-hydroxyphenylacetate (Saito et al, 2018) (Fig. 4B). Consistent and more interestingly, metabolites linked to gut microbial with the loss of microbial diversity in IBD, hydrocinnamate itself.

© The Author(s) Molecular Systems Biology Volume 20 | Issue 4 | April 2024 | 338 – 361